<DOC>
	<DOCNO>NCT03000907</DOCNO>
	<brief_summary>Rationale : There increase evidence obesity may risk factor frailty elderly . Obesity favor state chronic inflammation insulin resistance , involve fatty infiltration muscle increase cardiovascular risk , addition , obese people usually perform less physical activity . All favor loss mass muscular function ( sarcopenia ) , key component fragility functional deterioration . Objectives : To evaluate effectiveness multimodal intervention lose weight prevention frailty obese elderly people , well know main mechanism involve frailty process . Methodology : Design : Controlled , randomize , open-label clinical trial two parallel intervention arm 2 year follow-up . Study population : People 65 75 year age , obese ( BMI â‰¥30 ) , without criterion fragility live community . Study intervention : multimodal personalize intervention support `` personal trainer '' two main ax action : ) diet : assessment nutritional status nutritional requirement establishment personalize nutritional plan monthly dietetic control b ) physical exercise : multi-component physical exercise program include aerobic exercise strengthening , balance flexibility exercise well weekly group session health education , six month . Main outcome measure ( evaluate annually 2 year ) : Fragility ( accord L Fried criterion ) Sarcopenia ( accord criterion European Working Group Sarcopenia Older People -EWGSOP ) . Sarcopenia consider decrease gait velocity muscle grip strength ( measure dynamometer ) decrease muscle mass assess bioimpedance ( BIA ) . Intermediate outcome measure ( 6 , 12 24 month ) : ) weight loss , b ) change body composition distribution body fat , c ) glycemic control ( HbA1 ) insulin resistance ( HOMA index ( HOmeostasis Model Assessment ) ) , ) cardiovascular risk accord REGICOR algorithm , e ) functional capacity ( accord Barthel Index 2 Minute Walking Test ) , f ) inflammatory marker ( IL-6 , CRP ( C reactive protein ) , TNF ( Tumor Necrosis Factor ) -alpha leptin ) g ) anabolic hormone ( IGF-1 , ghrelin testosterone ) .</brief_summary>
	<brief_title>Efficacy Intervention Prevent Frailty Obese Elderly People ( PRE-FROB )</brief_title>
	<detailed_description />
	<mesh_term>Sarcopenia</mesh_term>
	<criteria>BMI 30 39 kg / m2 Non Frail accord L. Fried criterion At least one follow diagnosis : Oral glucose intolerance type 2 diabetes without insulin therapy . Dyslipidemia ( cholesterolemia &gt; 200 mg / dl triglyceridemia &gt; 150 mg / dl ) Arterial hypertension ( AT &gt; 120/90 mm Hg ) Relevant physical limitation due obesity Sleep apneahypopnea syndrome ( SAHS ) Give write informed consent participate study . Dementia neurodegenerative disease ( Parkinson 's disease ) Neuromuscular diseases Severe psychiatric illness , discretion physician , prevents good compliance study intervention Active cancer Life expectancy le 6 month Hemiplegia secondary stroke Amputation member Bariatric surgery tributary patient Institutionalized patient</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>prevention</keyword>
	<keyword>frailty</keyword>
	<keyword>obese</keyword>
	<keyword>elderly</keyword>
	<keyword>physical exercise</keyword>
</DOC>